Rezension:

I'm in a band online buy cialis sale articles on AAIP's regulatory solvency for the life segment at end-H113 improved to 2.44x from 1.88x in 2012, following an allocation of LKR500m of AAIP's total capital to the life business. This has supported premium growth and will also facilitate the anticipated split of life and non-life businesses as required by regulation. For non-life the solvency ratio deteriorated to 1.4x at end-H113 from 2.37x in 2012, mainly due to aggressive top line growth. Both ratios currently meet the regulatory requirement and the company has expressed its commitment to improve the non-life solvency ratio to above 3x by end-2013.

Bewertung: